Funding Opportunity PAR-24-276 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO), utilizing the U24 grant funding mechanism, encourages applications for a collaborating Data Coordinating Center (DCC) application that accompanies an investigator-initiated multi site clinical trial (Phase III and beyond) application submitted under companion PAR-21-243. The DCC application must be specific to the companion Clinical Coordinating Center (CCC) application. The objective of the DCC application is to propose a comprehensive plan that provides overall project coordination, and administrative, data management, and biostatistical support for the proposed clinical trial. Both a DCC application and a corresponding CCC application need to be submitted simultaneously for consideration by NCCIH. Trials for which this NOFO applies must be relevant to the research mission of NCCIH and considered a high priority by the Center. For additional information about the mission, strategic vision, and research priorities of NCCIH, applicants are encouraged to consult the NCCIH website (http://www.nccih.nih.gov). Applicants are encouraged to contact the appropriate Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this NOFO. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material.

Funding Opportunity PAR-24-275 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) encourages applications for investigator-initiated multi site clinical trials (e.g., efficacy, effectiveness, or pragmatic trials) to study the effects of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions), and/or multicomponent interventions that include physical, psychological, and/or nutritional approaches in NCCIH- designated areas of high research priority. Clinical Coordinating Centers (CCC) should develop and implement the proposed fully powered multi-site clinical trial (Phase III and beyond). The objective of a CCC application is to present the scientific rationale and a comprehensive scientific and operational plan for the clinical trial. CCC applications are expected to describe plans for project management, participant recruitment and retention strategies, performance milestones, scientific conduct, and dissemination of results. CCC applications submitted under this NOFO will utilize a two-phase, milestone-driven cooperative agreement (UG3/UH3) funding mechanism. In addition, an accompanying Data Coordinating Center (DCC) application (U24), submitted under PAR-24-087 proposing a data analysis and data management plan for the clinical project is required. Both a CCC application and a corresponding DCC application need to be submitted simultaneously for consideration by NCCIH. For additional information about the mission, strategic vision, and research priorities of NCCIH, applicants are encouraged to consult the NCCIH website: (https://nccih.nih.gov/about/plans). Applicants are encouraged to contact the appropriate Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this NOFO.

Funding Opportunity PAR-24-295 from the NIH Guide for Grants and Contracts. This is a reissue of the Emerging Global Leader Program (K43) to align with the clinical trials policy.

Funding Opportunity PAR-24-296 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA PAR-.The purpose of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to an early career research scientist from a low- or middle-income country (LMIC) who holds a junior faculty position at an LMIC academic or research institution, as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups , including low-income, lower-middle-income, and upper-middle-income countries). This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Funding Opportunity Announcement (FOA) invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors.

Funding Opportunity RFA-EB-25-002 from the NIH Guide for Grants and Contracts. The purpose of the Historically Black Colleges and Universities (HBCUs) Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) program is to enhance bioengineering and imaging research capacity, technology innovation, education and research training, and opportunities for scientific growth at HBCUs in order to utilize the Nation's full range of talent in meeting the growing need to accelerate the development and translation of high-impact biomedical innovation and technologies. The HBCU BEITA initiative will provide funding to strengthen the research capacity and technology innovation at HBCUs, accelerate technology development and implementation, and prepare students at HBCUs for careers in biomedical engineering, imaging, and technology (BEIT).

Notice NOT-OD-25-011 from the NIH Guide for Grants and Contracts

Negotiable: Oxford Nanopore Technologies: Based at our UK Head Office near Oxford, we are looking for a Manager to manage the regional Technical Application Scientists Team, and ensure that high quality support, training and consultancy is provided to Oxford Nanopore Customers. Oxford, England

Negotiable: Oxford Nanopore Technologies: Based at our UK Head Office near Oxford, we are looking for a Manager to manage the regional Technical Application Scientists Team, and ensure that high quality support, training and consultancy is provided to Oxford Nanopore Customers. Oxford, England

Competitive: Origin Sciences: Origin Sciences is a start-up biotechnology company based in Granta Park, just south of Cambridge. We develop our own innovative medical devices, whic Cambridge, United Kingdom

Competitive: Origin Sciences: Origin Sciences is a start-up biotechnology company based in Granta Park, just south of Cambridge. We develop our own innovative medical devices, whic Cambridge, United Kingdom

Competitive: King's College London: About us The School of Cardiovascular and Metabolic Medicine & Sciences (SCMMS) provides an outstanding multi-disciplinary environment for the pursu London, United Kingdom

GBP 46,148.00 - 52,809.00 per year: Oxford University Hospitals NHS Foundation Trust: Job summary BAND 7 POST IN CYTOGENETICS / CYTOGENOMICS We have an exciting opportunity for a registered clinical scientist to join our postnatal /rep Oxford, United Kingdom

Notice NOT-HD-24-034 from the NIH Guide for Grants and Contracts

Notice NOT-AR-24-020 from the NIH Guide for Grants and Contracts

Notice NOT-HS-25-003 from the NIH Guide for Grants and Contracts

Notice NOT-HS-25-004 from the NIH Guide for Grants and Contracts

Notice NOT-RM-24-013 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-179 from the NIH Guide for Grants and Contracts

Notice NOT-LM-24-004 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-NS-24-038 from the NIH Guide for Grants and Contracts. The NIH Blueprint for neuroscience is soliciting applications to pilot the establishment of an integrated resource for users to explore, analyze and download processed deidentified human brain single-cell transcriptomics and epigenomics data that is harmonized across reference and disease datasets. The resource will generate a unified cell type taxonomy, provide users with a draft annotatable cell-type nomenclature, and the ability to map community generated single cell omics data to the taxonomy. This pilot will lay the groundwork for an expanded and sustained effort to increase utility and accessibility of human cell-type classification data across multiple NIH consortia. BD